Samsung has announced that they’ve entered into an agreement with Consus Asset Management Co. to purchase a 43.5 percent stake in ultrasound device manufacturer, Medison and 100 percent of Prosonic Co. Ltd. that produces transducer probes and cables for ultrasound devices.
Samsung’s decision to pick up stake is a confirmation that the Korean giant is here to stay in the healthcare business and is in fact a part of Samsung’s Vision 2020 where they’ll invest up to 1.2 trillion won.
Samsung says “ultrasound diagnostics device segment provide a logical entry point into the healthcare equipment market due to technological similarities and potential synergies with Samsung’s existing consumer electronics and IT products and technologies.”
